Stockwinners Market Radar for August 15, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:30 EDT Cathie Wood's ARK Investment bought 297.5K shares of Ginkgo Bioworks today

19:36 EDT Distribution Solutions declares two-for-one stock split - Distribution Solutions announced that its Board of Directors has approved and declared a two-for-one split of the Company's common stock, $1.00 par value per share. The Stock Split will entitle each stockholder of record as of the close of business on August 25, 2023 to receive one additional share of Common Stock for each share of Common Stock then held, to be distributed by the Company's transfer agent Computershare after the close of trading on August 31, 2023. Stockholders do not need to exchange existing stock certificates to receive additional Shares.

19:00 EDT MediciNova receives new patent covering MN-001 - MediciNova announced it has received a Decision to Grant from the European Patent Office for a new patent which covers MN-001 for the treatment of scleroderma and/or systemic sclerosis. This patent is expected to expire no earlier than June 2035. The allowed claims cover the use of MN-001 for inhibiting or treating scleroderma and/or systemic sclerosis. The allowed claims cover oral administration, including tablets and capsules, as well as liquid dosage forms. The allowed claims cover a wide range of doses and a range of different dosing frequencies. Kazuko Matsuda, M.D. Ph.D., MPH., Chief Medical Officer, MediciNova, Inc., commented, "This new patent is based on positive results from a systemic sclerosis animal model study conducted recently. The Canadian Intellectual Property Office granted a similar patent earlier this year. We are very pleased to receive notice of this new patent which covers Europe, and we believe it could increase the potential value of MN-001."

18:52 EDT Coherent falls 9% to $42.53 after Q1, FY24 guidance miss estimates

18:37 EDT Four Corners Property Trust announces sale leaseback of four Tire Discounters - Four Corners Property Trust announces the acquisition of four Tire Discounters properties for $9.1 million via sale-leaseback transaction. Tire Discounters is the country's largest family-owned and operated automotive service provider, currently operating over 200 retail locations and growing. The properties are located in Virginia (2), Georgia (1), and Ohio (1), and are corporate-operated under long-term, triple net leases. The transaction was priced at a cap rate in range with previous FCPT transactions.

18:20 EDT CME Group exec Holzrichter sells 6,000 class A shares - In a regulatory filing, CME Group senior MD chief operationg officer Julie Holzrichter disclosed the sale of 6,000 class A common shares of the company on August 15 at a price of $205.4701 per share.

18:00 EDT Pono Capital Three Inc trading resumes

17:47 EDT Mercury Systems down 11% at $30.21 after Q4 miss, below-consensus guidance

17:41 EDT Cava Group jumps 8% to $50.20 after Q2 earnings beat

17:25 EDT TFS Financial Chairman Stefanski sells $176K in shares - Chairman of TFS Financial Marc Stefanski disclosed the sale of 11,813 shares of company stock at $14.96 per share on August 11, for a total transaction amount of $176,722.

17:18 EDT Impel in forbearance discussions with Oaktree Fund Administration - As previously disclosed, the Company estimated that it had sufficient capital to fund operations into the third quarter of 2023, and would need to raise additional capital to avoid defaulting under its senior credit agreement with Oaktree Fund Administration as administrative agent and the lenders party thereto, or collectively Oaktree. As of the date hereof, the Company has been unsuccessful in identifying potential financing opportunities and is in breach of the covenant under the Senior Credit Agreement to maintain a minimum of $12.5M in unrestricted cash and cash equivalents on hand. The Company is currently in negotiations with Oaktree regarding a potential forbearance and restructuring of the Senior Credit Agreement and with Oaktree and other investors regarding the terms of an approximately $20M potential bridge financing facility. The Company continues to negotiate these terms, and as such, requires additional time to finalize the required disclosures in its Form 10-Q. For these reasons, the Company has determined that it is unable to file its Form 10-Q within the prescribed time period without unreasonable effort or expense. The Company anticipates that the Form 10-Q will be filed as soon as practicable and prior to or on the fifth calendar day following the prescribed due date...While the Company continues to pursue actions and steps to improve its cash position and mitigate any potential liquidity shortfall, based on recurring losses and negative cash flow from operations for the six months ended June 30 as well as current cash and liquidity projections, the Company has concluded that there is substantial doubt about the Company's ability to continue as a going concern. As of June 30, the Company had approximately $15.2M in cash and cash equivalents.The Company continues to consider all strategic alternatives including restructuring or refinancing its debt, seeking additional debt or equity capital, reducing or delaying the Company's business activities and strategic initiatives, or selling assets, other strategic transactions and/or other measures, including obtaining relief under the U.S. Bankruptcy Code. These measures may not be successful.

17:13 EDT Pono Capital Three Inc trading halted, news pending

16:59 EDT YouTube Music debuts, Samples, a new personalized music discovery feature - T. Jay Fowler Director of Product Management, YouTube Music bloggedin part earlier: "At YouTube Music, we're making it easier than ever to discover new music you'll love. Starting today, we're introducing the Samples tab, a seamless feed of short form video segments to get you to your new favorite music. Powered by the world's largest catalog of music videos, this personalized feed will explore the depths and breadth of the YouTube Music library so that there's always something new to listen to, whether it's the latest release from an up-and-coming artist or a deep cut from a legacy artist we just think you'd really like. Each immersive clip offers a glimpse into the artist, the video, and the feel of the song. Users can simply swipe vertically to experience a new song, making music discovery fun and effortless... for artists, the Samples tab provides another way to find a new audience and build a community on YouTube...The Samples tab is beginning to roll out today to YouTube Music users globally. In the future, we'll explore how this type of short-form discovery can inform other parts of the YouTube Music app and look for opportunities to provide joyful new experiences that make it easy to discover new artists and their music. Start the beginning of your next great music journey with the Samples tab!" Reference Link

16:35 EDT Geospace signs $3M mariner rental agreement - Geospace Technologies announced a rental contract with Walker Marine Geophysical, a high resolution land and marine seismographic surveyor provider who will rent 3,000 of the new product, Mariner, shallow water seabed wireless seismic data acquisition nodes. Based on current contract terms, the minimum value of the agreement is $3.2M. The delivery of Mariners will occur in Geospace's third quarter of fiscal year 2024. "We appreciate longtime customers such as Walker Marine who continue to recognize the value of gathering high quality data for their customers," said Walter R. Wheeler, President and CEO, Geospace Technologies. "In today's competitive ocean bottom node market, companies with staying power are choosing to protect their reputation and future business by selecting top quality seismic survey tools like Mariner. By including valuable features such as our internal heading sensor and built-in full resolution test generator, we ensure our customers deliver high quality results to their customers."

16:31 EDT Granite awarded $215M contract by the city of Akron - Granite has been awarded an approximately $215M contract by the city of Akron, Ohio to construct the Northside Interceptor Tunnel Project, or NSIT, to aid in preventing combined sewer overflows from entering the Cuyahoga River during typical storms. Project funding will come from the Ohio Environmental Protection Agency's Water Pollution Control Loan Fund, or WPCLF, and is expected to be included in Granite's third-quarter CAP. The NSIT, a crucial component of the U.S. Environmental Protection Agency's mandated Consent Decree, is set to revolutionize the city's sewer infrastructure and significantly reduce combined sewer overflows. The project is planned to begin in September 2023 and is expected to be completed in July 2027.

16:31 EDT FMC Corporation granted preliminary injunction against Rainbow Agro Sciences - FMC "announced the Mexican Federal Court of Administrative Justice, Specialized Court in Intellectual Property, granted FMC Corporation and FMC Agroquimica de Mexico, S. de R. L. de C.V. a preliminary injunction against Rainbow Agro Sciences, S.A. De C.V. for patent infringement relating to the company seeking registration of chlorantraniliprole and chlorantraniliprole-containing products in Mexico. Chlorantraniliprole is FMC's leading insecticide ingredient branded as Rynaxypyr(R) active."

16:20 EDT Occidental Petroleum to acquire Carbon Engineering for $1.1B - Occidental announced that a wholly owned subsidiary has entered into a definitive purchase agreement to acquire all the outstanding equity of Carbon Engineering for total cash consideration of approximately $1.1B, to be made in three approximately equivalent annual payments, with the first at closing. This transaction is expected to close before the end of 2023, subject to Canadian court reviews, Canadian and U.S. regulatory approvals and other customary closing conditions. Occidental has been working with Carbon Engineering on direct air capture, or DAC, deployment since 2019. Acquiring Carbon Engineering aligns with Occidental's integrated net-zero strategy and provides Occidental, through its 1PointFive subsidiary, the opportunity to rapidly advance DAC technology breakthroughs and accelerate deployment of DAC as a large-scale, cost effective, global carbon removal solution. Carbon Engineering's DAC-based climate solutions utilize standardized processes and proven industrial equipment.

16:17 EDT LGL Group names Timothy Foufas co-CEO - The LGL Group announced that on August 11, 2023, the Board of Directors elected Ms. Darlene DeRemer and Mr. Herve Francois to the Board, effective immediately. Marc Gabelli, LGL Chairman added, "We are delighted that both Ms. DeRemer and Mr. Francois have joined our board, and that Tim Foufas has moved into management. Darlene brings 35 years of experience in asset management and investment banking. Herve offers 20 plus years' experience in technology investing as well as broad financial analysis acumen. Tim has over 25 years as an investor. These additions will assist our management team as we continue to evaluate LGL opportunities for shareholder value creation." In addition, the Company announced that Timothy Foufas, a long time LGL Board member, has joined the company as Co-CEO, as Michael Ferrantino transitions from management to the Board. "This continues the management transition following the spin-off of M-tron Industries, Inc. late last year. I am delighted Tim will move to take on this executive role. He brings a long history of private equity and operational experience," said Michael Ferrantino.

16:14 EDT DLocal says 'clearly trading' towards higher end of revenue outlook - The company said, "We are very proud of our half year results and we reaffirm our guidance for the year of revenue between US$620 and US$640 million and Adjusted EBITDA between US$200 and US$220 million. We are clearly trading towards the higher end of that guidance in terms of revenue, but prefer to take a conservative approach given the macro environment. Specific changes of circumstances such as the devaluation of the Nigerian Naira affect our revenue number, but not our gross profit. The annual guidance we have provided accounts for close to 50% year-on-year growth at best in class margins. This would be a great outcome for our 2023 results and testament to the resilience and well-diversified business we are building. We reiterate our mid-term guidance of 25%-35% gross profit CAGR and Adjusted EBITDA over gross profit greater than75%, which are best in class metrics."

16:13 EDT Booz Allen director Shrader sells 100,000 class A shares - In a regulatory filing, Booz Allen director Ralph Shrader disclosed the sale of 100,000 class A common shares of the company on August 11 at a price of $120.56 per share.

16:12 EDT Cava Group sees FY23 adjusted EBITDA $62M-$67M - Sees FY23 Net New CAVA Restaurant Openings at 65 to 70 and CAVA Same Restaurant Sales Growth at 13.0% to 15.0%.

16:09 EDT DLocal names Pedro Arnt co-Chief Executive Officer, board member - DLocal Limited announced that Pedro Arnt has been appointed as co-Chief Executive Officer and member of the Board of Directors of the Company, effective immediately, to serve as co-Chief Executive Officer alongside Sebastian Kanovich. Mr. Arnt has extensive leadership experience in the tech sector and as a public company executive, having spent over 25 years in operations, strategy and finance, including most recently as Chief Financial Officer for the last twelve years at Mercado Libre, one of the largest technology companies with operations in Emerging Markets.

16:04 EDT DLocal up 18% afterhours after Q2 results and guidance at $18.27

16:01 EDT AngioDynamics receives FDA breakthrough device designation for AngioVac system - AngioDynamics announced that the U.S. Food and Drug Administration has granted Breakthrough Device designation for the company's AngioVac System for the proposed indications for use to include the non-surgical removal of vegetation from the right heart. The FDA Breakthrough Device designation is designed to help patients gain timely access to medical devices that may provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions for which no approved or cleared alternatives exist. "The FDA's recognition of the AngioVac System and its potential to provide a novel and innovative treatment pathway for the non-surgical removal of vegetation from the right heart represents a significant step in our journey to advance patient care," said Jim Clemmer, AngioDynamics' President and Chief Executive Officer. "The support of our physician partners continues to lead us in the development, study and application of this innovative technology to treat and manage critical medical conditions for a patient population with an unmet need."

16:00 EDT DLocal Ltd trading resumes

15:55 EDT DLocal Ltd trading halted, volatility trading pause

15:12 EDT First Solar falls after internal audit finds forced labor in Malaysia - First Solar disclosed in its sustainability report for 2023 that its audits found four onsite service providers in Malaysia employed foreign migrant workers who were subjected to unethical recruitment including the payment of recruitment fees in their home countries, passport retention and the unlawful retention of wages. As a result of the findings, the service providers have since returned all passports and unlawfully retained wages to the workers, the company said. It updated its site service agreements to prevent any recurrence of the issue. "Furthermore, after developing a reimbursement plan with a third party, we are now working with our onsite service providers to ensure the recruitment fees are reimbursed to their current and former employees," First Solar noted. Shares of First Solar are down 5% to $200.83 in afternoon trading. Reference Link

14:21 EDT AvalonBay exec Lockridge sells 3,331 common shares - In a regulatory filing, AvalonBay Communities executive VP Joanne Lockridge disclosed the sale of 3,331 common shares of the company on August 11 at a price of $186.25 per share.

14:05 EDT Mallinckrodt pays half of late interest, 'actively engaged' in talks - Mallinckrodt entered into certain extensions to its forbearance agreements, pursuant to which the applicable creditors and agents have agreed to forbear from exercising any rights or remedies with respect to the events of default arising from the company's failure to make interest payments. Pursuant to the extension agreement, Mallinckrodt has agreed to pay approximately $19M, plus accrued interest thereon, representing 50% of the interest payment originally due on June 15. The company expects to pay the remaining amount of such interest payment, including accrued interest thereon, in connection with signing a potential restructuring support agreement. Mallinckrodt said its board continues to actively evaluate the company's financial situation and consider options, and that the company "is actively engaged in advanced discussions with various stakeholders." These discussions contemplate entering into a restructuring support agreement withs various stakeholders that would include, among other things, the company's initiating Chapter 11 proceedings. The contemplated Chapter 11 proceedings would cause the company's ordinary shares to be canceled, which would result in no recovery for holders of its ordinary shares, it added.

13:35 EDT Global Blue jumps 10% to $5.10 after Reuters says Silver Lake exploring sale

13:04 EDT PNAC Stock trading resumes

12:54 EDT PNAC Stock trading halted, volatility trading pause

12:00 EDT Jumia Technologies falls -14.0% - Jumia Technologies is down -14.0%, or -52c to $3.20.

12:00 EDT Sea Limited falls -27.7% - Sea Limited is down -27.7%, or -$15.77 to $41.13.

12:00 EDT Paysafe rises 23.6% - Paysafe is up 23.6%, or $2.79 to $14.61.

11:57 EDT Ionis granted orphan status for ALS treatment - The FDA granted Ionis Pharmaceuticals orphan status for ulefnersen, its treatment of amyotrophic lateral sclerosis. Reference Link

11:04 EDT Blue Bird delivers 20 electric school buses to Miami-Dade County Public Schools - Blue Bird Corporation is supplying 20 electric school buses to Miami-Dade County Public Schools in Florida, the first zero-emission vehicles in the districts' all Blue Bird fleet of school buses.

10:44 EDT Walmart+ members to receive accelerated savings on fuel - Walmart (WMT) announced that it is joining forces with Exxon Mobil (XOM) to double the discount Walmart+ members currently receive at Exxon and Mobil stations nationwide, from 10 cents to 20 cents off every gallon of gas. The 2x discount will begin August 15 at about 12,000 participating stations and will continue to pump savings into members' wallets through September 15, the company said in a statement. "We know that fuel savings is a huge benefit for our Walmart+ members, one that really adds up," said Venessa Yates, SVP and general manager of Walmart+.

10:38 EDT JX Luxventure collaborates with Hainan Airlines for ticket sales - JX Luxventure subsidiary, Beijing Heyang International Travel Agency signed a passenger transport sales agency agreement with Hainan Airlines pursuant to which Hainan Airlines appointed Heyang as the regional agent for ticket sales of domestic and international routes, including specially managed domestic regional routes.

10:05 EDT Hawaiian Electric cut to BB- at S&P, watch Negative - S&P Global Ratings downgraded Hawaiian Electric and all of its rated subsidiaries to 'BB-', and at the same time placed these entities on CreditWatch with negative implications. S&P said: "We also lowered the short-term and commercial paper ratings to 'B'. The CreditWatch placement with negative implications reflects the potential for additional downgrades of one or more notches within the coming months." S&P commented: "Hawaii has been devastated by the worst wildfires in its history, with nearly 100 fatalities, and about 2,200 structures damaged or destroyed. Separately, class-action lawsuits have been filed against Hawaiian Electric Industries Inc., and its subsidiaries, Hawaiian Electric Co. Inc., Maui Electric Co. Ltd., and Hawaii Electric Light Co. Inc., which has increased the risk of a material deterioration in HEI's credit quality, should the plaintiffs prevail."

10:01 EDT Wendy's announces opening of first Global Next Gen restaurants - The Wendy's Company announced the opening of the first Global Next Gen restaurants, while also finalizing a new Global Next Gen High-Capacity Kitchen design option for the highest customer demand. Both digital-first designs were created to enhance customer, crew and franchisee experiences, accelerating growth across Wendy's global restaurant footprint, Wendy's said in a statement. "The Global Next Gen future-forward design unlocks 400 times the capacity for digital orders, accelerating the System's digital growth," said Wendy's President, International & Chief Development Officer Abigail Pringle. "By bringing Global Next Gen from cutting-edge blueprints to successful openings in less than one year, Wendy's global structure is enabling System-wide expansion optimized to the digital age."

10:00 EDT Gol Linhas falls -13.6% - Gol Linhas is down -13.6%, or -51c to $3.21.

10:00 EDT Paysafe rises 11.2% - Paysafe is up 11.2%, or $1.32 to $13.14.

10:00 EDT LL Flooring rises 26.0% - LL Flooring is up 26.0%, or 97c to $4.72.

09:49 EDT BNY Mellon Wealth Management appoints Sinead Colton-Grant as CIO - BNY Mellon Wealth Management announced the appointment of Sinead Colton-Grant as Chief Investment Officer, effective January 1, 2024. Colton-Grant will succeed Leo Grohowski who has decided to retire at the end of this year. Colton-Grant is based in New York and reports to Catherine Keating, Global Head of BNY Mellon Wealth Management. Grohowski has been CIO of BNY Mellon Wealth Management for 16 years and has over four decades of asset and wealth management industry experience. He played a pivotal role in shaping investment strategy and execution, and successfully guided clients through multiple business cycles. With more than 25 years of investment experience, Colton-Grant is currently Head of Investor Solutions at BNY Mellon and previously was Deputy Chief Investment Officer and Head of Equities for BNY Mellon Wealth Management. As part of the transition, Chris Vella, Chief Investment Officer for Investor Solutions, will lead the Investor Solutions business. Prior to joining BNY Mellon, Vella spent 20 years at Northern Trust Asset Management, including as Chief Investment Officer of Multi-Manager Solutions overseeing investment strategy, manager selection and portfolio construction.

09:47 EDT Getty Images falls -11.2% - Getty Images is down -11.2%, or -51c to $4.04.

09:47 EDT LL Flooring rises 11.3% - LL Flooring is up 11.3%, or 43c to $4.18.

09:47 EDT Grindr rises 20.9% - Grindr is up 20.9%, or 98c to $5.67.

09:41 EDT Nano Dimension receives purchase order for additive robotics solutions - Nano Dimension has received its largest single purchase order in the history of the company, both in terms of the dollar value and number of systems. The order for digital manufacturing additive robotics solutions was from a Western highly advanced industrial leader. The sale includes multiple robotics systems designed and made by integrated technologies from Nano Dimension' divisions. The advanced Additive Robotics manufacturing equipment are critical in modern digital-industrial production.

09:36 EDT Ault Inc. announces settlement of SEC investigation - Ault announced that the company, executive chairman Milton Ault, and CEO William Horne have reached a settlement with the U.S. Securities and Exchange Commission, or SEC, to fully resolve the SEC's previously disclosed investigation into certain of the company's public disclosures and its accounting for certain transactions, among other matters. Under terms of the settlement, the company, Ault, and Horne neither admit nor deny the SEC's findings, which do not entail intentional misconduct. The company will pay a civil penalty of $700,000 that was fully accrued in the fourth quarter of 2022; Ault will pay disgorgement of $85,504 and a civil penalty of $150,000 and Horne will pay a civil penalty of $20,720. In addition, the company has undertaken to retain an independent consultant to conduct a comprehensive review of the company's internal control over financial reporting and disclosure controls and procedures, and to issue a report providing recommendations for improvements.

09:34 EDT Altisource Asset Management trading halted, volatility trading pause

09:29 EDT Moringa Acquisition contributes to trust account for proposed extension - Moringa Acquisition announced that, in connection with its previously announced extraordinary general meeting in lieu of the 2023 annual general meeting of shareholders of the Company to be held at 9:00 a.m. Eastern Time/4:00 p.m. local time on August 16, 2023 for the purpose of considering and voting on, among other proposals, a proposal to extend the date by which the Company must consummate an initial business combination from August 19, 2023 to August 19, 2024 or such earlier date as may be determined by the Company's board of directors, in its sole discretion, the Company's sponsor, Moringa Sponsor, L.P., and/or its wholly-owned subsidiary Moringa Sponsor, or the Sponsor's designees, will make additional contributions to the Company's trust account following the approval and implementation of the Extension. If the requisite shareholder proposals are approved at the Extraordinary Meeting and the Extension is implemented, the Sponsor or its designees will deposit into the Company's trust account as a loan, on the Current Termination Date, and the 19th day of each subsequent calendar month until, but excluding, the Extension Date, the lesser of $15,000 and $0.025 per public share multiplied by the number of public shares outstanding on such applicable date.

09:21 EDT Home Depot says Q2 gross margin 33%, down 8 bps y/y due mostly to shrink

09:19 EDT Wheels Up Experience trading halted, news pending

09:17 EDT Avantax welcomes over 100 independent Financial Professionals during 1H23 - Avantax welcomed more than 100 independent Financial Professionals during the first two quarters of 2023. Established wealth managers, newly licensed tax professionals and licensed tax professionals are choosing Avantax because they want superior service and innovative growth support from their broker dealer as well as the peer-to-peer collaboration that comes with joining the Avantax Community. During the second quarter Avantax reported newly recruited assets of approximately $141 million. Also, during the second quarter, 50 independent Financial Professionals affiliated with Avantax, including Frank Calise, who transferred to Avantax from Securities America, a broker-dealer of Advisor Group.

09:16 EDT On Holding down 10% at $31.15 in pre-market after Q2 results and guidance

09:16 EDT Novo Integrated Sciences, Farm 7 Group announce Kenya cooperative ag pact - Novo Integrated Sciences announced the Company and Farm 7 Group Inc., a Canada corporation , have entered into a joint venture agreement relating to the development, administration and arrangement of structured financing for the implementation and commencement of the Kenya Agricultural Cooperative Project , a Kenya centric agricultural project with finalized and executed uptake contracts for food-based agricultural goods on up to 9 million hectares with potential revenue up to $350M. The JV Agreement, which has an initial term of 30 years, provides for the annual distribution of the net profits 75% to F7 and 25% to Novo. Robert Mattacchione, Novo's CEO and Chairman of the Board, stated, "With F7 having secured guaranteed commodity buyer contracts for annual delivery of up to 1.6 million metric tons of food-based harvested commodities such as cassava starch, yellow corn, wheat, soybean, and sunflower, the project is anticipated to have significant financial impact on both organizations. Novo will be providing all administration and structured finance solutions to the joint venture."

09:16 EDT Urban-Gro awarded $1.5M contract from healthcare sector client - urban-gro announced that the Company was awarded a $1.5 million contract to provide architecture, interior design, and engineering services to a healthcare sector client in the southeastern United States. The Company anticipates that the majority of the revenue from this project will be recognized over the next four quarters.

09:13 EDT TeleVox adds wayfinding solution to its patient engagement platform - TeleVox has announced a new partnership with Gozio Health, a location aware digital health platform, to help patients find their way to medical appointments on time. Access to Gozio's platform, including patented wayfinding, can now be integrated and offered through appointment reminders and hospital visits managed through TeleVox. This will save patients time, improve on-time visits for patients and providers, and ensure revenue is optimized. TeleVox is a part of West Technology Group, LLC controlled by affiliates of certain funds managed by Apollo Global Management.

09:13 EDT LitePoint provides Wi-Fi 6E/7 test solution for Wi-Fi Alliance - LitePoint announced its collaboration with Wi-Fi Alliance to support Automatic Frequency Coordination certification on its IQxel-MW 7G test platform.

09:11 EDT Kartoon Studios creates limited-edition digital artwork for transition to NYSE - Kartoon Studios announces its will provide an exclusive piece of AI-enhanced, digital art featuring characters from its library of animated content, to its shareholders of record on June 26, 2023, the Company's first day trading on the NYSE under its new ticker "TOON". Formerly known as Genius Brands International, Inc., the company changed its name to Kartoon Studios, when transitioning to the NYSE. As the Company builds its assets of timeless and positive animated IP for children, it wishes to show its appreciation to shareholders during this transition into its next phase of growth, trading on NYSE.

09:11 EDT Noodles & Company signs multi-unit franchise deals in Texas and Arkansas - Noodles & Company added two new franchise partners to its network in the southern U.S. who signed an agreement to open four new restaurants in Northwest Arkansas and 20 restaurants in the Dallas market. Noodles & Company is focused on expanding its franchise footprint in south and southeast markets, with a focus on increasing its presence in Alabama, Florida, Georgia, Texas, and Oklahoma.

09:09 EDT Paylocity enters an exclusive partnership with Elatia Abate - Paylocity announced an exclusive partnership with Elatia Abate as Futurist in Residence. "Paylocity is committed to building the most modern HCM solutions on the planet. As a reflection of that commitment, we're partnering with industry-leading experts whose academic research is focused on studying the Future of Work. We believe Elatia's first-person perspective as a previous HR executive will resonate deeply with our clients who are leading through uncertainty every day," said Steve Beauchamp, co-CEO of Paylocity. Abate will examine where Paylocity clients are today, where they are likely to be tomorrow and share best practices to assist Paylocity's clients of all sizes. She will offer an external view into HR and modern workforce trends, as well as the evolution of technology and its impact on work, sharing those observations, conclusions, and predictions with Paylocity leaders and clients alike.

09:08 EDT First Solar expands collaboration with UbiQD on quantum dot solar modules - First Solar has entered into a joint development agreement with UbiQD, a New Mexico-based nanotechnology company, to further collaborate on developing the potential to incorporate fluorescent quantum dot technology in advanced solar modules. The two companies have been conducting exploratory work since early 2022, and the initial results have supported the more formalized joint-development effort. Quantum dots are semiconductor nanoparticles that exhibit high efficiency photoluminescence over a wide range of tunable colors, making them effective at optimizing light spectra.

09:07 EDT Eaton Partners expands Private Capital Advisory Services - Eaton Partners announced the expansion of its newly branded Private Capital Advisory business. PCA will be organized into four distinct specialties - GP Solutions, LP Solutions, Direct Equity, and GP Stakes - to provide financial sponsors and their investors with differentiated strategic advice and liquidity solutions, in combination with the broader Stifel Investment Banking platform. Firm veterans Dexter Blake and Peter Martenson will lead the team's LP Solutions and Direct Equity specialties, respectively. Charles Korchinski will spearhead the GP Stakes offering. As part of this enhanced effort, Eaton Partners is pleased to announce the hiring of experienced secondary transaction advisor Dirk Jonske as Managing Director to spearhead the GP Solutions specialty. Prior to joining Eaton Partners, Mr. Jonske was in Credit Suisse's Private Fund Group, where he was responsible for the origination and evaluation of private equity primary, secondary, and co-investment transactions with a focus on providing strategic advice regarding continuation vehicles. Before joining Credit Suisse, Mr. Jonske was an Executive Director in the Private Fund Group at UBS and a Senior Associate on the Private Equity Investment team at Landmark Partners. Gabrielle Kim, Arielle Mandelbaum, and William Daniel, all formerly of Credit Suisse, have also joined Eaton Partners as Director, Vice President, and Analyst, respectively.

09:06 EDT OKYO Pharma reports FY23 R&D $6.3M vs $1.6M last year - OKYO ended the period with $4.0 million cash as of 31 March 2023 as compared to $2.7 million on 31 March 2022. Gary Jacob, Chief Executive Officer of OKYO, commented, "We are very pleased at the advancements we have made with our flagship drug OK-101 to treat DED this year. On May 2, 2023, we announced the initiation of our first clinical trial of OK-101 to treat DED. This trial is a 240 patient, phase 2, multi-center, randomized, double-masked, placebo-controlled trial in patients with DED. This summer we are expecting to see considerable enrollment of patients in the ongoing trial and are presently on track to have top line data released in Q4 2023. I am also excited about OK-101's dual combination of anti-inflammatory ocular activity and neuropathic corneal pain (NCP) reducing activity. NCP is a debilitating condition characterized by chronic and severe eye discomfort, leading to decreased quality of life for affected individuals. There is presently no FDA approved drug to treat NCP and we were pleased to recently announce our plan to open a small trial of OK-101 to treat patients with NCP at Tufts Medical Center in Boston. We remain steadfast in our dedication to advancing groundbreaking ocular solutions that have the potential to transform patients' lives. Our team's resilience and unwavering focus on research and development will continue to be the driving force behind our progress. We are actively exploring opportunities to optimize our operational efficiency and enhance our partnerships within the industry. Thank you to our employees, partners, and shareholders for their continued support as we work diligently to bring about a new treatment to benefit the many millions of patients suffering from DED."

09:04 EDT Avidity Biosciences' AOC 1044 granted FDA Orphan Drug designation in DMD - Avidity Biosciences announced that the FDA has granted Orphan Drug designation to AOC 1044, the company's investigational therapy in development for the treatment of Duchenne muscular dystrophy, or DMD, in people with mutations amenable to exon 44 skipping. DMD is a rare genetic condition that is characterized by progressive muscle damage and weakness due to the loss of dystrophin protein that typically starts at a very young age. Currently, there are no therapies approved targeting exon 44. AOC 1044 is being assessed in the Phase 1/2 EXPLORE44 clinical trial for people living with DMD44 and is the first of multiple AOCs in development at Avidity for the treatment of DMD. Avidity plans to share results from the healthy volunteer portion of the EXPLORE44 trial in Q4 and is now enrolling participants living with DMD44 into the study. In April 2023, AOC 1044 received FDA Fast Track designation for the treatment of DMD44.

09:02 EDT Thomson Reuters enters partnership with Right Networks - Right Networks announced a new partnership with Thomson Reuters to offer cloud hosting of its tax and accounting solutions, in the United States. As part of the multi-year collaboration, tax and accounting officers can now leverage Right Networks' secure, scalable cloud hosting with Thomson Reuters' software suite, including UltraTax CS and SurePrep.

09:02 EDT Broadcom announces 512-port, 256-port Brocade X7 Directors - Broadcom announced the availability of the industry's most secure and highest density Gen 7 64G Fibre Channel Director- the 512-port and 256-port Brocade X7 Directors. The company also announced the Brocade 7850 Extension Switch, the industry's first 64G Fibre Channel switch, extending SANs over virtually any distance across the globe. This latest product launch further expands Broadcom's Brocade 64G Fibre Channel portfolio, demonstrating unmatched industry innovation and technology leadership. The company also continues to address customer requirements related to data center infrastructure security and resiliency with a cyber-resilient SAN that mitigates cybersecurity and downtime risks.

08:51 EDT Mercurity Fintech's Ucon Capital approved to enter 'Cyberport' community - Mercurity Fintech Holding announced that its wholly-owned subsidiary, Ucon Capital, has been honored with the approval to join the "Cyberport", an innovative digital community managed by Hong Kong Cyberport Management Company Limited.

08:47 EDT Gilead sees transaction with Tentarix to reduce EPS by 3c-4c - Beginning in the first quarter of 2022, consistent with recent industry communications from the U.S. Securities and Exchange Commission SEC , Gilead no longer excludes acquired IPR&D expenses from its non-GAAP financial measures. Gilead see the transaction with Tentarix to reduce Gilead's GAAP and non-GAAP 2023 EPS by approximately 3c-4c.

08:43 EDT Sarepta director buys $1.09M in common stock - In a regulatory filing, Sarepta disclosed that its director Michael Chambers bought 9,979 shares of common stock on August 14th in a total transaction size of $1.09M.

08:39 EDT Orion Energy announces launch of new TritonPro, Harris exterior LED products - Orion Energy Systems announced the launch of its new TritonPro product category and new Harris exterior LED lighting products. The launch comprises five new cutting-edge products that provide proprietary Orion design, quality and value-pricing to expand the Company's reach into new construction and retrofit markets and to meet requests from channel partners. The new products are: TritonPro Compact Linear High Bay; TritonPro LED Slimline Lumen Select Vaportight; TritonPro LED Troffer Lumen Select; TritonPro LED Lumen Select Strip Retrofit; and Harris Area Light Lumen Select. "We are excited to expand the breadth and capability of our LED lighting solutions with these innovative new Orion-designed solutions," said Mike Jenkins, Orion CEO. "The TritonPro series expands our reach, value proposition and leadership in the lighting industry. These new products also reaffirm our commitment to driving innovation with cutting-edge technology, outstanding performance, and energy-efficient lighting solutions to meet an expanding range of applications for our customers."

08:37 EDT ElectraMeccanica, Tevva to combine in plan of arrangement - ElectraMeccanica and Tevva announced that they have entered into a definitive arrangement agreement, pursuant to which ElectraMeccanica and Tevva have agreed to combine by way of a British Columbia statutory plan of arrangement. The attending members of the boards of directors of both companies unanimously approved the proposed transaction. The proposed transaction with ElectraMeccanica and Tevva is the culmination of a formal process initiated by ElectraMeccanica's board of directors to explore a range of possible strategic alternatives for optimizing ElectraMeccanica's assets and generating sustained shareholder value while still managing potential risks. Upon the closing of the proposed transaction, ElectraMeccanica shareholders will own 23.5% of the combined company and Tevva shareholders will own 76.5% of the combined company on a fully diluted basis. The combined company expects to have a cash balance of approximately $70M-80M, with debt of approximately $26M. At closing of the proposed transaction, the combined company will operate as Tevva, Inc., and is expected to be domiciled in Delaware. It is anticipated that the combined company and its shares will trade on The Nasdaq Capital Market under the ticker symbol TVVA, subject to the receipt of all applicable Nasdaq approvals. The combined company is expected to benefit from the acceleration of Tevva's U.S. market entry, supported by the complementary platform, team, and assets of ElectraMeccanica, in addition to anticipated long-term reductions in material costs. The transaction is also expected to deliver approximately $5M in run-rate annual cost savings by year-end 2024. The board of directors of the combined company will consist of nine directors, comprising five directors from Tevva and four directors from ElectraMeccanica, of which seven are expected to be deemed independent. The senior executive team of the combined company will reflect the significant talent and experience at the leadership level of both companies. Following the completion of the proposed transaction, it is expected that Susan Docherty will become CEO of the combined company. The proposed transaction will be completed, subject to the definitive arrangement agreement, by way of a court-approved plan of arrangement under the Business Corporations Act, whereby a newly formed British Columbia corporation, created to manage and hold the combined business of ElectraMeccanica and Tevva, will, directly and indirectly, acquire all of the issued and outstanding equity securities of ElectraMeccanica and Tevva. In addition, concurrent with the announcement of the proposed merger, the board of ElectraMeccanica has approved, under certain conditions, the provision of a $6M credit facility to Tevva which can be drawn in whole or in part until the closing of the proposed transaction. If drawn, the credit facility is intended to provide Tevva with additional working capital to accelerate delivery of commercial vehicles to fleet customers. The proposed transaction is expected to close in Q4, following the satisfaction or waiver of closing conditions, including, among others, required approvals of ElectraMeccanica's and Tevva's shareholders of the proposed transaction, the approval of the Supreme Court of British Columbia of the proposed transaction, and the conditional approval for the shares of the resulting Issuer to be listed on of Nasdaq. All officers and directors of ElectraMeccanica support the transaction and have entered into support and voting agreements for all of their shares, including ElectraMeccanica's founder and largest shareholder. This cumulatively represents 9.67M shares, or approximately 7.89% of ElectraMeccanica's outstanding shares. In addition, the aforementioned ElectraMeccanica shareholders and key shareholders of Tevva, have entered into lock-up agreements in connection with the proposed transaction, which will subject them to a 180-day restricted period, subject to certain release exemptions based on the trading level of the combined company's stock price.

08:36 EDT Quisitive partners with Heart-Tech Health for cardiac health innovation - Quisitive Technology has partnered with Heart-Tech Health to implement MazikCare as an Integrated Care Delivery tool to prevent women's heart disease. Quisitive has partnered with Heart-Tech Health to implement its MazikCare Care Path solution within Adesso to empower patients and providers to collaborate on comprehensive care plans by facilitating the seamless transfer of information between care teams and creating pathways from risk identification to proven interventions. The solution will enable patients to access lifestyle and diagnostic screenings, view recommended lifestyle changes that create true health impact, and efficiently connect to providers to improve health outcomes. The value-based care platform will help eliminate unnecessary testing and reduce ER visits and hospitalizations, decreasing overall spending on heart-related health matters.

08:34 EDT Moxian regains compliance with Nasdaq minimum bid price rule - Moxian received notification from The Nasdaq Stock Market confirming the Company has regained compliance with NASDAQ's minimum bid price requirement under Listing Rule 5550(a)(2). NASDAQ noted this matter is now closed.

08:34 EDT NeoGames signs agreement with Scientific Games - NeoGames has signed an agreement with Scientific Games to deliver its premium NeoGames Studio content to the Pennsylvania Lottery. The three-year deal will see NeoGames Studio's rich portfolio of engaging titles integrated onto the Scientific Games platform, providing the Pennsylvania Lottery's customers with a wide range of award-winning eInstant games which will be rolled out across the coming year. The new partnership further expands NeoGames' increasing support for lottery customers in North America, with a total of eight lotteries on the continent set to carry the supplier's iLottery offering. Hili Shakked, Managing Director of NeoGames Studio, said: "Through this partnership with Scientific Games and the Pennsylvania Lottery, we are able to bring our premium eInstant games to a large new market of players. This collaboration is a further illustration of our commitment to providing innovative, engaging games that meet the needs of lottery customers. We are confident that this long-term agreement will be a win-win for all stakeholders."

08:33 EDT Microbot Medical boosts manufacturing, commercialization ability for its system - Microbot Medical announces another step in its commitment to advance the commercialization processes of LIBERTY with the signing of a manufacturing agreement with B.Y. Medimor Ltd. The agreement governs the manufacturing of the Company's LIBERTY Robotic Surgical System, for its first in human clinical trial as well as for the initial LIBERTY systems that are expected to be marketed following the completion of regulatory requirements. "We continue our transition from a research and development stage to a clinical and commercial stage in the field of endovascular robotics," commented Simon Sharon, Microbot's CTO and General Manager. "We believe that the manufacturing agreement supports our efforts to deliver a state-of-the-art advanced robotic system and facilitates our next steps."

08:18 EDT Futuris acquires healthcare staffing business from Recruiter.com - Recruiter.com announced Futuris Company has reached an agreement to acquire the Company's specialized healthcare staffing business, pending client approvals. This strategic move cements Futuris' place within the healthcare staffing industry and underscores both companies' shared commitment to expanding services and promoting growth. According to the agreement's terms, Recruiter.com will transition specific client contracts to Futuris or its related entities. The transaction compensation incorporates Futuris stock, valued at $500,000, and a share of the ongoing gross profit, with a maximum limit of $2 million. The transaction is expected to close immediately upon the fulfillment of closing conditions, including necessary client approvals.

08:16 EDT Blink Charging expands EV charging infrastructure across Latin America - Blink Charging is expanding its footprint in Latin America, LATAM, to become a leader in growing the EV charging market within the region. Notably, Latin America experienced a remarkable 57% surge in EV charger sales during the first quarter of 2023 compared to the figures at the close of 2022. Since its entry into the Latin American market in 2020, Blink has firmly established a strong presence, having sucessfuly sold or deployed more than 2,100 EV chargers across eight countries. The Company's success can be attributed to its wide, diverse range of state-of-the-art and user-friendly product offerings, encompassing Level 2 chargers tailored to different plug types commonly found throughout LATAM. "To prepare for and embrace an electrified future in Latin America, our efforts throughout the region - focused on developing and offering the most advanced EV charging technologies - are immense," said Juan Barahona, US & Global Director of Operations for Blink Charging. "Blink is also closely monitoring the evolving needs of the region guaranteeing our continued provision of products and services essential to support the distinct EV implementation goals in each individual country."

08:10 EDT Skyward Specialty adds Ashe to its board of directors - Skyward Specialty Insurance (SKWD) announces the addition of Gena Ashe to its Board of Directors as an independent director effective August 14, 2023. Ashe has more than 30 years of broad-based senior executive experience with public and private companies in various industries, including telecommunications, broadcasting, hospitality, big data, and logistics. She currently serves as the Chief Legal Officer and Corporate Secretary of Anterix (ATEX).

08:07 EDT ABM to manage parking operations at Oracle Park - ABM has entered into a three-year agreement to manage parking operations for Oracle Park in San Francisco, California. ABM will be managing three separate parking facilities at the home to Major League Baseball's, MLB, San Francisco Giants. This partnership builds upon ABM's substantial parking facility management presence across San Francisco, including its position as the largest operator in the Financial District. In all, ABM serves more than 100 stadium and entertainment venues in the U.S., including six MLB ballparks as well as the Golden 1 Center for the nearby Sacramento Kings. "We're excited to partner with the Giants and the Oracle Park team to further enhance the fan, player, and employee experience through our parking management services," said Josh Feinberg, EVP and Chief Strategy & Transformation Officer and Head of ABM Parking & Transportation. "Our award-winning expertise in parking operations will match their competitive drive and help provide a fan experience second-to-none." Through a combination of smart technology and industry-leading expertise, ABM provides a platform for simple online payments, connectivity to loyalty programs, and seamless online reservations to enhance the overall parking experience.

08:05 EDT Akari Therapeutics announces ADS Ratio change - Akari Therapeutics announced that Akari will change the ratio of its American Depositary Shares to ordinary shares from one ADS representing one hundred ordinary shares to a new ratio of one ADS representing two thousand ordinary shares. The ratio change is expected to be effective on August 17, 2023. The ratio change is intended to enable Akari to regain compliance with the Nasdaq minimum bid price requirement. On the effective date, each ADS holder will be required to exchange every twenty ADSs for one new ADS. Deutsche Bank, the depositary bank, will arrange for the exchange of the current ADSs for the new ADSs. There is no change to Akari's underlying ordinary shares, and Akari's ADSs will continue to trade on the NASDAQ Capital Market under the symbol AKTX.No fractional new ADSs will be issued in connection with the change in the ADS ratio. Instead, fractional entitlements to new ADSs will be aggregated and sold and the net cash proceeds from the sale of the fractional ADS entitlements will be distributed to the applicable ADS holders by Deutsche Bank.

08:04 EDT DZS to debut multiple BABA-Ready EDGE innovations at Fiber Connect - DZS will be showcasing many of its latest innovations and expert insights at Fiber Connect 2023, the world's leading optical fiber business technology event, hosted by the Fiber Broadband Association and taking place in Orlando, Florida, August 20 - 23. With bridging the digital divide being a pervasive theme on most attendees minds, DZS will highlight on the show floor a variety of disruptive and Build America, Buy America-ready Access EDGE, Subscriber EDGE, Optical EDGE and Cloud EDGE solutions targeting this challenge and opportunity, including its recently launched DZS FiberWay solutions, the industry's first comprehensive hardened edge broadband offering designed to address the needs of reaching unserved and underserved markets. A Platinum Sponsor of the event, DZS leaders will also be providing fresh perspectives across a wide array of speaking topics at the event, including a keynote panel on the influence of "AI on In-Home Experience" as well as breakouts focused on last-mile and middle-mile technologies and regulatory insights.

08:04 EDT Petco, Ollie's Human-Grade Pet Nutrition announce partnership - Petco Health and Wellness Company and dog nutrition brand Ollie announced an exclusive partnership to bring Ollie's human-grade fresh and baked food, treats and supplements for dogs to Petco customers. Previously only available direct-to-consumer through an online subscription, Ollie's high-quality assortment can now be shopped in a variety of flexible ways at petco.com/Ollie, via the Petco app, and in most Petco pet care centers nationwide by the end of September. By the end of September, Ollie will be at nearly 800 Petco pet care centers nationwide.

08:02 EDT Humacyte presents clinical performance of HAV from Ukranian Humanitarian Program - Humacyte presented yesterday at MHSRS the clinical results of a year-long humanitarian program in Ukraine. The Company's investigational Human Acellular Vessel was provided to five hospitals on the frontlines to treat traumatic vascular injuries beginning in June 2022. War injuries in Ukraine have led to tens of thousands of amputations, many of which occur because blood flow cannot be restored after the injury. As of July 2023, the HAV has been used to treat 19 patients in Ukraine suffering from a range of traumatic vascular injuries, including gunshots, shrapnel, blasts, and industrial accidents. Clinicians reported that the rate of success in treating patients with the HAV was high, with an observed 30-day HAV patency of 95%. At 30 days after treatment with the HAV, the limb salvage rate was 100%, meaning no amputations occurred in patients treated with the bioengineered vessel. In addition, there was 100% patient survival and no cases of infection of the HAV. There was one patient whose HAV had to be removed due to shrapnel-related bleeding. Humacyte's humanitarian program was initiated in May 2022, when the company provided investigational HAVs to hospitals in Vinnytsia, Dnipro, Odessa, Kyiv, and Kharkiv, in response to Ukrainian surgeon requests. Humacyte worked closely with the International Office of the U.S. Food and Drug Administration and the Ukrainian Ministry of Health to obtain approval for the program. Humacyte then subsequently trained Ukrainian surgeons by video conference on how to implant the HAV. The HAV, an innovative regenerative medicine product candidate, is designed to provide surgeons with a universally implantable, bioengineered human vessel. It is intended to be available to the surgeon immediately and provide a potentially life and limb saving option in circumstances where synthetics are not indicated and autologous vein is not feasible. Designed to be off-the-shelf, the HAV has the potential to save valuable time and reduce complications like amputations and tissue loss. Additionally, the HAV is comprised of the same tissue that makes up natural human vessels, thereby having the potential to repopulate with the patient's own cells. Clinical results suggest that the HAV is durable and highly infection-resistant, and therefore may be well suited for treating the contaminated wounds created by major wartime blast and shrapnel injuries. Importantly, the HAV can be produced at commercial scale in Humacyte's existing manufacturing facilities, providing thousands of vessels for treating injured patients. The new data demonstrating the HAV's success on the frontlines in Ukraine will be included as part of the data in the Humacyte's Biologics License Application (BLA) to the FDA, which is planned for fourth quarter 2023. The planned BLA will build on results from Humacyte's pivotal trial studying the HAV in treating patients with vascular injury in the extremities, which recently completed enrollment. The HAV also received the FDA's Regenerative Medicine Advanced Therapy designation in May 2023 for urgent arterial repair following extremity vascular trauma. The RMAT designation allows for close collaboration between Humacyte and the FDA during the application process.

07:54 EDT DocGo launches partnership with EmblemHealth - DocGo announced the launch of its partnership with EmblemHealth. DocGo will work closely with EmblemHealth to bring in-home services to New York and Connecticut patients after hospitalization to close preventive health care gaps. Through the partnership, patients will receive in-home healthcare services, including transitional care management following recent hospital discharges. Bringing care to members' homes makes preventive screenings and chronic care management more accessible. Available services include diabetic retinal eye exams, bone density tests, A1C screenings, blood pressure control support, and colorectal cancer screenings. Bringing these services into the home can lead to earlier disease detection, prevent many avoidable escalations, and help patients stay out of the hospital.

07:41 EDT Newmont receives clearance from KFTC to acquire Newcrest - Newmont Corporation announced that the Korea Fair Trade Commission, KFTC, has cleared the Company to proceed with its proposed acquisition of Newcrest Mining Limited , stating that the transaction does not violate Korea's Monopoly Regulation and Fair Trade Law. Newmont continues advancing other regulatory approvals and expects to close the transaction in the fourth quarter of this year. Earlier this month, Papua New Guinea's PNG Independent Consumer & Competition Commission cleared the proposed acquisition while the Canadian Competition Bureau issued a "no action" letter in July clearing the transaction. Other regulatory approvals to be secured for Newmont's proposed acquisition of Newcrest include the Australian Competition and Consumer Commission ACCC, the Australia Foreign Investment Review Board FIRB, the Japan Fair Trade Commission, and the Philippine Competition Commission, PCC. Newmont and Newcrest also continue engaging with the PNG Government and regulators about other approvals and clearances for the transaction. On May 14, Newmont announced its definitive agreement to acquire Newcrest. The combination would create a world-class portfolio of assets with the highest concentration of Tier 1 operations, primarily in favorable, low-risk mining jurisdictions. Upon closing of the transaction, the combined company would deliver a multi-decade production profile from 10 large, long-life, low cost, Tier 1 operations, and increased annual copper production primarily from Australia and Canada. The combined business is anticipated to generate annual pre-tax synergies of $500M, expected to be achieved within the first 24 months, while also targeting at least $2B in the first two years after closing through portfolio optimization.

07:38 EDT Sonoma Pharmaceuticals receives NEA Seal of Acceptance for Reliefacyn - Sonoma Pharmaceuticals announced that Reliefacyn Advanced Itch-Burn-Rash-Pain Relief Hydrogel has received the National Eczema Association Seal of Acceptance.

07:37 EDT Amesite announces partnership renewal with CMU - Amesite announces the renewal of its partnership with the Central Michigan University, CMU. The U.S. Continuing Education market is expected to from USD 60.52B in 2022 to an estimated USD 93.25B by 2028, with a compound annual growth rate of approximately 7.47%. There are 474 regional public universities in the US that all stand to benefit from launching professional upskilling programs. Amesite CEO Dr. Ann Marie Sastry said, "Partnership renewals validate our business model. Leveraging our state-of-the-art Version 6.3 platform with the latest GPT-4 technology and our comprehensive integration capabilities, we are able to launch solutions quickly and efficiently that generate sustainable university revenue in professional learning, and drive growth for Amesite."

07:36 EDT Dragonfly Energy expands operations with new distributor, midwest location - Dragonfly Energy (DFLI) is expanding to the Midwest. Through its partnership with a new distributor and the establishment of a Midwest office, the Company will establish a geographic foothold and streamlined access to a significant region for the RV and trucking markets; which Dragonfly Energy serves with its popular Lithium-ion battery Battle Born Batteries products. "Exceptional customer service is one of our core business values, and by expanding our footprint, we believe we can more efficiently serve our growing customer needs in the Midwest and East Coast markets," said Dr. Denis Phares, Chief Executive Officer of Dragonfly Energy. "We already have a strong presence in the West, so this new office represents another physical milestone for our growing company." Located in Indiana, the Midwest Dragonfly Energy office will house senior sales members and technical support staff as well as product storage, enabling improved efficiencies and quicker shipping to the East Coast and Midwest regions. Additionally, the Company has engaged the services of UFP Distribution LLC (UFPI), a subsidiary of UFP Industries. UFP Distribution will serve as a fulfillment center, perform sales support and offer light manufacturing assistance.

07:35 EDT Interactive Strength announces non-binding LOI of intent, exclusivity agreement - Interactive Strength announce that it has entered into a non-binding letter of intent, LOI, and exclusivity agreement to acquire a connected fitness equipment business. The potential transaction, if consummated, is expected to accelerate FORME's commercialization path, result in immediate scale across all functions and create a high-growth and profitable platform that sells connected fitness equipment and digital fitness services across B2B and B2C channels. This strategic move is also expected to provide FORME and the target company with enhanced cross-selling opportunities and improved penetration into new end markets. FORME's due diligence review of the target acquisition has already commenced, and upon satisfactory completion, the Company intends to proceed towards executing a definitive acquisition agreement and closing the transaction as soon as all closing conditions are met by all parties involved. Proposed Transaction Highlights: The proposed acquisition is expected to yield several strategic and financial benefits, positioning the combined entity for further growth: Rationale: Provides immediate scale in all functions; Generates material and near-term cashflow for FORME; Diversifies revenue, with significant growth in B2B channel; Opportunity for strong B2B distribution partner for FORME hardware products; Solidifies position as the premium platform in the Connected fitness industry. Pro forma financials : Combined Gross revenues in 2023 are projected to exceed $10 million; Combined Gross revenues in 2024 are projected to exceed $25 million; Cashflow positive and adjusted EBITDA positive by the fourth quarter of 2024. Consideration: All of the equity of the target company is anticipated to be exchanged for TRNR equity at close of transaction, and with the same shareholder "lock-up" as pre-IPO shareholders; Earn-out potential for 2024 paid in TRNR equity, with Enterprise Value / 2024 Gross Revenue multiple of approximately 1.2x remaining constant; Minimal cash for working capital; Assumption of target debt. Valuation: Approximately 1.2x Enterprise Value / 2024 Gross Revenues; Between 5x and 6x Enterprise Value / EBITDA pro-forma for projected synergies. Timing: Close as early as the fourth quarter of 2023.

07:25 EDT Alterity Therapeutics receives A$4.74M R&D tax incentive refund - Alterity Therapeutics has received a A$4.74M cash refund from the Australian Taxation Office under the Australian Government's Research and Development Tax Incentive Scheme. The cash refund relates to the cost of eligible research and development activities conducted during the financial year ended 30 June 2022, and represents the amount disclosed in the company's audited financial statements. These funds will be used to further Alterity's clinical development and research activities, including the ongoing Phase 2 clinical trials for the Company's lead drug candidate ATH434 in Multiple System Atrophy, a Parkinsonian disorder with no approved therapy.

07:15 EDT Freedom Holding sinks 13% to $65.51 after Hindenburg short report

07:14 EDT Amicus announces approval, launch of new Pompe disease therapy in U.K. - Amicus Therapeutics announced that the Medicines and Healthcare products Regulatory Agency, MHRA, of the United Kingdom has granted marketing authorizations for Pombiliti + Opfolda for adults living with late-onset Pompe disease. The indication for Pombiliti is a long-term enzyme replacement therapy, ERT, used in combination with miglustat for adults with late-onset Pompe disease, LOPD. The indication for Opfolda is an enzyme stabilizer of cipaglucosidase alfa long-term enzyme replacement therapy for adults with LOPD. In addition, the National Institute for Health and Care Excellence, NICE issued final guidance recommending reimbursement of Pombiliti + Opfolda for use within the National Health Service, NHS in England and Wales. As stated in the guidance, NICE concluded that the cost-effectiveness estimates for Pombiliti + Opfolda showed a positive net health benefit and recommended Pombiliti + Opfolda for adults with LOPD as first line and later lines of therapy. "The MHRA approvals for Pombiliti and Opfolda are a major step forward for adults in the U.K. living with late-onset Pompe who are seeking new treatments. We are grateful to the global Pompe community who have helped advance this therapy, especially the patients, families, and physicians who participated in our clinical studies," stated Bradley Campbell, President and Chief Executive Officer of Amicus Therapeutics, Inc. "The speed in which NICE recommended reimbursement of Pombiliti and Opfolda is reflective of the U.K.'s Innovative Licensing and Access Pathway, the data behind Pombiliti and Opfolda, the strong collaboration with the reimbursement authorities, and the Amicus commitment to bring this therapy to those living with Pompe disease as quickly as possible. I am proud of Amicus' relentless commitment toward ensuring patient access to our innovative therapies, and we are working as quickly as possible to make Pombiliti and Opfolda commercially available."

07:12 EDT White Gold commences maiden diamond drilling at Cali target - White Gold (WHGOF) announced the commencement of its maiden diamond drilling program at the Cali target on the Nolan property, in the White Gold District, situated in the west-central region of the Yukon, Canada. The Cali target is located approximately 77 km west from Dawson City via the Top of the World Highway, connecting Dawson City to Alaksa, and is perched in the hills surrounding the Sixty Mile River. Historically, the Sixty-Mile River has produced significant amounts of placer gold since the late 19th century, however the area has received minimal modern hard rock exploration. Planned maiden diamond drilling at Cali in 2023 is designed to test for gold mineralization along a continuous 2 km long multi-element soil anomaly coincident with the Sixtymile-Pika Fault, a large regional structure which bisects the property. The Cali target represents one of the Company's several compelling grassroot projects in the underexplored White Gold District which provide the opportunity for new discoveries in addition to the Company's recently announced gold discoveries and its flagship White Gold Project which comprises 16 million tonnes averaging 2.23 g/t Au for 1,152,900 ounces of gold in the Indicated Resource category and 19 million tonnes averaging 1.54 g/t Au for 942,400 ounces of gold in the Inferred Resource category which remains open for expansion. This drill program forms part of the Company's 2023 fully funded program on its extensive 350,000 hectare land package in the emerging White Gold District, Yukon, supported by strategic partners Agnico Eagle Mines Limited (AEM) and Kinross Gold Corporation (KGC). Cam Norton, Exploration Manager for White Gold states, "The maiden diamond drilling of the Cali target represents an exciting opportunity for White Gold. We have always been impressed with the scale of the Cali soil anomaly, the favourable geological setting, and the convenient road accessibility from Dawson City."

07:10 EDT Green Thumb Industries to open RISE Dispensary Fruitland Park in Florida - RISE Dispensaries announced that RISE Dispensary Fruitland Park, the Company's 8th retail location in Florida and 85th nationwide, will open on August 16th. The new dispensary will host a grand opening event on August 25th, where profits from the day will be donated to Minorities for Medical Marijuana.

07:09 EDT Gritstone bio, Genevant Sciences announce option, license agreement - Gritstone bio and Genevant Sciences announced an agreement pursuant to which Gritstone bio will have a multi-year option for a non-exclusive license under Genevant's LNP technology on a pathogen-by-pathogen basis to develop and commercialize self-amplifying RNA vaccines. "Our previous collaborations with Genevant have demonstrated the powerful potential of combining the strengths of two technology leaders, and we are pleased to expand our relationship with this new agreement," said Andrew Allen, M.D., Ph.D., Co-founder, President and Chief Executive Officer of Gritstone bio. "With the established complementarity between our samRNA technology and Genevant's LNP technology, evident in clinical datasets in both oncology and infectious disease, we are now even better positioned to capitalize on the emergence of RNA vaccines and therapeutics to address a broader array of infectious diseases." Under the terms of the agreement, Genevant is eligible to receive from Gritstone option maintenance and exercise fees in the single digit millions, up to $136M in contingent milestone payments per product, subject to increase for multi-pathogen products and in other specified circumstances, and royalties ranging from the mid to high single digits on future product sales.

07:08 EDT Omniq selected for approximately $50M project from a food, drug chain in U.S. - OMNIQ announced that it has been awarded with a project expected to exceed $50M from one of the largest food and drug chains in the US. The project aims to modernize and enlarge the logistics system of this multi-billion dollar long standing customer. Shai Lustgarten, CEO of omniQ, stated, "Our team has diligently worked over the last six months on securing the $50m project, focusing on design and seamless integration within the customer's logistics system. Our efforts have culminated in success, and we take pride in once again receiving a strong vote of confidence from one of the largest and most prestigious corporations worldwide. The unwavering dedication of our team to meet the ever-evolving demands of our long-standing customers has played a pivotal role in nurturing enduring partnerships. This project, coupled with our robust pipeline and backlog, will undoubtingly have a positive impact on the Company's performance throughout 2023 and beyond."

07:06 EDT Tiziana Life Sciences announces FDA IND clearance of intranasal foralumab - Tiziana Life Sciences announced that the U.S. Food and Drug Administration, FDA, has cleared the Investigational New Drug, IND, application for intranasal foralumab to be studied in Alzheimer's disease. Foralumab could be a potentially groundbreaking treatment for Alzheimer's disease, given it targets the disease's underlying pathology by addressing the resulting neuroinflammation caused by the accumulation of toxic proteins in the brain. Gabriele Cerrone, Chairman, acting CEO and founder of Tiziana Life Sciences, stated, "The IND clearance is a significant milestone for Tiziana that highlights the strength and the therapeutic potential of foralumab. We are deeply committed to advancing the field of neurodegenerative diseases and bringing much-needed relief to patients suffering from Alzheimer's with a novel therapeutic approach. We are thrilled to have reached this critical juncture and are eager to move forward with the necessary trials to evaluate the effectiveness of foralumab in Alzheimer's disease in combination with an FDA approved therapy or as a single agent."

07:04 EDT Freeline expects initial clinical data from GALILEO-1 trial in Q3 - Initial clinical data, with a focus on assessments of safety and enzyme activity, from the first cohort of the GALILEO-1 Phase 1/2 trial of FLT201 is expected in the third quarter of 2023. GALILEO-1 is a first-in-human, international, multicenter Phase 1/2 dose-finding study assessing the safety, tolerability, and efficacy of a single intravenous dose of FLT201, the company's adeno-associated virus gene therapy candidate for Gaucher disease Type 1.

06:58 EDT Glatfelter announces sale of Ober-Schmitten, Germany facility - Glatfelter announced the sale of Glatfelter Ober-Schmitten GmbH and certain related distributor operations in Asia to Ostrest GmbH, a company owned by Ilkem Sahin, the chairman of the board of IS Holding A.S. Ostrest GmbH to assume ownership effective August 15, with site to remain fully operational.

06:52 EDT Brookfield Business Partners renews normal course issuer bids - Brookfield Business Partners announced that the Toronto Stock Exchange has accepted a notice filed by the company of its intention to renew its normal course issuer bid for its limited partnership units and another for its class A exchangeable subordinate voting shares. Brookfield Business Partners is authorized to repurchase up to 3,730,658 Units and 3,647,745 Exchangeable Shares, representing up to 5% of the issued and outstanding Units and Exchangeable Shares, respectively. At the close of business on August 8, 2023, there were 74,613,176 Units and 72,954,912 Exchangeable Shares issued and outstanding. Repurchases under each normal course issuer bid are authorized to commence on August 17, 2023 and will terminate on August 16, 2024, or earlier should Brookfield Business Partners or Brookfield Business complete repurchases under each respective normal course issuer bid prior to such date. No Exchangeable Shares were purchased under Brookfield Business Corporation's previous normal course issuer bid in the past twelve months.

06:13 EDT CBS names McMahon president, CEO of CBS News, Stations, CBS Media Ventures - Wendy McMahon has been named president and chief executive officer, CEO, of CBS News and Stations and CBS Media Ventures, expanding her role to include singular oversight of CBS News and Stations as well as leadership of CBS' domestic syndication business. The announcement was made today by George Cheeks, president and chief executive officer of CBS, to whom McMahon reports. In this newly created role and structure, McMahon will now lead all of CBS News' broadcast and streaming operations, 27 local television stations in major U.S. markets, 14 local news streaming channels and CMV's top-rated first-run syndication programming, as well as its content licensing to television stations and the division's national advertising sales business. McMahon was previously appointed president and co-head of CBS News and Stations in May 2021.

05:58 EDT Netflix testing games on more devices - Netflix on Monday began the first public tests of its cloud-streamed games. Some Netflix subscribers in Canada and the UK are now able to check out Netflix games streamed to select TVs, connected TV devices, and on the web from Netflix.com, Netflix VP of Games Mike Verdu said in a blog post. "Two games will be part of this initial test: Oxenfree from Night School Studio, a Netflix Game Studio, and Molehew's Mining Adventure, a gem-mining arcade game," Verdu said of the "limited" beta test. Reference Link

05:25 EDT Nokia, Nomios and Geant to triple capacity for European research network - Nokia, Nomios Group and Geant announced that Geant, the collaboration of European National Research and Education Networks, or NRENs, will deploy a IP/MPLS solution from Nokia as part of a 10-year frame agreement led by Nomios Group, a leading European provider of cybersecurity services and solutions. As part of its GN5 IP/MPLS routing and switching replacement project, Geant will be the first NREN in the world to deploy 800 Gigabit Ethernet, or GE, routing interfaces, tripling capacity and supercharging its 50,000 km network by establishing a resilient and secure foundation for extreme collaboration and knowledge sharing amongst an international alliance of researchers. Geant interconnects 40 NRENs in 40 European countries, and links 50M users and institutions to more than 100 additional NRENs in every region of the world. The high-performance IP backbone network will be the foundation for a global coalition of researchers focused on breakthrough research across disciplines such as high-energy physics, biomedicine, radio astronomy, and climate-impacting weather conditions. Over the past five years, the Geant network has experienced 30% traffic growth each year and is now carrying more than seven Petabytes of data daily. This is due, in large part, to the proliferation of instruments such as telescopes, sensors and detectors, which gather more data with greater precision, sensitivity and speed. Supercomputers process vast volumes of data, analyzing and validating findings. Given the high level of collaboration between allied institutions, that data must be transferred rapidly, reliably, securely, and cost-effectively. The Geant GN5 IP/MPLS Routing and Switching Infrastructure Replacement project represents a strategic go-to-market partnership between Nomios and Nokia, bringing together Nomios' extensive experience in designing and implementing robust networking solutions, combined with Nokia's expertise in delivering cutting-edge IP network technology for the world's most critical networks. Under the terms of the agreement, Nomios and Nokia will undertake the complete replacement and upgrade of Geant's existing IP/MPLS routing and switching infrastructure, ensuring enhanced scalability, security, and reliability for Geant's extensive network operations. Additionally, Nomios and Nokia will provide comprehensive support and maintenance services to ensure uninterrupted connectivity and smooth operations for Geant and its vast user base.

05:19 EDT Liberty Global, Infosys expand collaboration - Liberty Global (LBTYA) and Infosys (INFY) announced that they have expanded their collaboration to evolve and scale Liberty Global's cutting-edge digital entertainment and connectivity platforms. Building on their existing multi-year collaboration which has supported Liberty Global's technology services platforms since February 2020, the companies will significantly expand the program, with Infosys taking over build and operations of Liberty Global's award-winning Horizon entertainment and connectivity platforms. By bringing the scale and breadth of Infosys, including cutting-edge technologies such as Infosys Topaz AI offering, the expanded collaboration ensures continued operational excellence, a highly scalable development engine for new features and capabilities, and efficiencies for Liberty Global. The parties have entered into an initial five-year agreement, with an option to extend to 8 years and beyond. Infosys will provide services to Liberty Global estimated at EUR 1.5B over the initial five-year term and at EUR 2.3B if the contract is extended to eight years. The collaboration allows Liberty Global to realize run-rate savings in excess of EUR 100M per annum, inclusive of other savings and technology investments. In addition, Liberty Global is licensing these platforms to Infosys so the digital services provider can offer best-in-class services to new operators and new markets outside the Liberty Global family. This will potentially enable millions of new customers, around the world, to experience next-generation digital entertainment and connectivity services through Horizon for the first time. Liberty Global will continue to control product roadmaps and retain all intellectual property for the Horizon entertainment and connectivity platforms. The expanded collaboration will additionally create exciting career opportunities for more than 400 Liberty Global employees joining Infosys, who will benefit from its global scale and reach. Under the terms of the business arrangements, senior executives and technology teams from Liberty Global's Product, Technology Development Service Delivery Group, Network & Shared Operations and Security Groups will transition to Infosys. They will benefit from global business exposure, scale, and wider career advancement opportunities. They will also play an important role in shaping the future of Infosys' communications, media and entertainment business and add significantly to its engineering capabilities.